GLP-1 Race and Pfizer's MetSera Acquisition

Jim Cramer analyzes Pfizer's $10B MetSera purchase, monthly shot strategy, and competition with Lilly's weekly shot and pill efforts.

Play episode from 44:38

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!